Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe community-acquired pneumonia.

S Ewig1, A Torres

  • 1Department of Internal Medicine, Medizinische Universitätsklinik Bonn, Germany.

Clinics in Chest Medicine
|October 12, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU.

The European respiratory journal·1998
Same author

Subclavian vascular access stenosis in dialysis patients: natural history and risk factors.

Journal of the American Society of Nephrology : JASN·1998
Same author

ATP-sensitive K+ channel blocker glibenclamide and diaphragm fatigue during normoxia and hypoxia.

Journal of applied physiology (Bethesda, Md. : 1985)·1998
Same author

Prognostic significance of p53 gene mutations in squamous cell carcinoma of the lung.

Oncology reports·1998
Same author

[Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].

Revista de neurologia·1998
Same author

[Estimation of cardiac vagal reserve by dynamic exercise in patients with recent myocardial infarction].

Archivos del Instituto de Cardiologia de Mexico·1998

Severe community-acquired pneumonia (CAP) requires prompt antimicrobial therapy for better outcomes. Key factors influencing prognosis include patient health, treatment appropriateness, and disease severity.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Critical Care Medicine

Background:

  • Severe community-acquired pneumonia (CAP) is a critical condition, often necessitating hospitalization and carrying significant mortality.
  • It disproportionately affects individuals with comorbidities like COPD, alcoholism, heart disease, and diabetes.
  • Common pathogens include S. pneumoniae, Legionella spp., GNEB, H. influenzae, S. aureus, M. pneumoniae, and respiratory viruses.

Purpose of the Study:

  • To outline the critical aspects of managing severe CAP, focusing on diagnosis, treatment, and prognosis.
  • To emphasize the importance of timely and appropriate antimicrobial interventions.
  • To discuss prognostic factors and emerging therapeutic strategies.

Main Methods:

  • Review of existing literature and clinical guidelines for severe CAP management.

Related Experiment Videos

  • Analysis of common causative organisms and their susceptibility patterns.
  • Identification of key prognostic indicators and treatment recommendations.

    • Main Results:

    • Mortality rates for severe CAP range widely from 21% to 54%.
    • Prognostic factors include patient's overall health, timeliness of antimicrobial treatment, presence of bacteremia, severity of respiratory failure, sepsis, shock, and radiographic findings.
    • Initial empiric antimicrobial therapy, often involving cephalosporins and erythromycin, is crucial.

    Conclusions:

    • Early, appropriate antimicrobial treatment is paramount for improving outcomes in severe CAP.
    • Treatment strategies should be individualized based on patient comorbidities and local resistance patterns.
    • Ongoing research into non-antimicrobial treatments like ventilation and immunomodulation holds promise.